Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of September 10, 2026, BHVN trades at $13.31 with a market cap of $2.22B and a P/E ratio of -2.23. BHVN moved -11.29% today. Year to date, BHVN is +32.86%; over the trailing twelve months it is +3.59%. Its 52-week range spans $7.48 to $44.28. Analyst consensus is buy with an average price target of $21.56. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Biohaven Ltd. (BHVN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BHVN moved -11.29% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $13.31 |
| Market Cap | $2.22B |
| P/E Ratio | -2.23 |
| EPS | $-6.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.28 |
| 52-Week Low | $7.48 |
| Volume | 45.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-738.82M |
| Gross Margin | 0.00% |
11 analysts cover BHVN: 0 strong buy, 8 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.56.